Serum gamma-glutamyl transferase activity is an independent predictor for cardiovascular disease in Obstructive Sleep Apnea Syndrome

Respiratory Medicine

Volumn 105, Issue 4, 2011, Pages 637-642

  Kanbay, Asiye ^a   Kaya, Elif ^a   Buyukoglan, Hakan ^a   Ozdogan, Nezihe ^a   Kaya, Mehmet Gungor ^a   Oymak, Fatma Sema ^a   Gulmez, Inci ^a   Demir, Ramazan ^a   Kokturk, Oguz ^b  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

C Reactive protein; Cardiovascular disease; Gamma glutamyl transferase; Obstructive sleep apnea

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE;

ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; ENZYME ACTIVITY; GROUPS BY AGE AND SEX; HEART ARRHYTHMIA; HEART FAILURE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SLEEP APNEA SYNDROME;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANOXIA; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE;

EID: 79952280681     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.12.003     Document Type: Article

References (32)

1. Weiss JW, Launois SH, Anand A, et al. Cardiovascular morbidity in obstructive sleep apnea. Prog Cardiovasc Dis 1999;41:367-76. (Pubitemid 29300425)
2. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab 2001;86:3815-9. (Pubitemid 32755982)
3. Shetty GK, Economides PA, Horton ES, et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004;27:2450-7. (Pubitemid 39281400)
4. Oflaz H, Cuhadaroglu C, Pamukcu B, et al. Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension. Respiration 2006;73:751-6. (Pubitemid 44795920)
5. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001;38:263-355. (Pubitemid 32826505)
6. Lee DH, Ha MH, Kim JH, et al. Gamma-glutamyltransferase and diabetesea 4 year follow-up study. Diabetologia 2003;46:359-64.
7. Lee DH, Jacobs Jr DR, Gross M, et al. Gamma-glutamyl-transferase is a predictor of incident diabetes and hypertension: the coronary artery risk development in Young adults (CARDIA) study. Clin Chem 2003;49:1358-66. (Pubitemid 36900623)
8. Emdin M, Passino C, Michelassi C, et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 2001;22:1802-7. (Pubitemid 32929115)
9. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.
10. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and treatment of high blood cholesterol in adults (Adult treatment Panel III). JAMA 2001;285:2486-97.
11. Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-87. (Pubitemid 46924065)
12. Rechtschaffen AKA, editor. A Manual of standardized Terminology, techniques, and scoring System for sleep Stages in human subjects. Los Angeles, CA: VCLA; 1968.
13. EEG arousals: Scoring rules and examples: a preliminary report from the sleep disorders Atlas task force of the American sleep disorders association. Sleep 1992;15:173-84.
14. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 1999;22:667-89.
15. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
16. Persijn JP, van der Slik W. A new method for the determination of gamma-glutamyltransferase in serum. J Clin Chem Clin Biochem 1976;14:421-7.
17. Ikeda Y, Fujii J, Taniguchi N, et al. Expression of an active glycosylated human gamma-glutamyl transpeptidase mutant that lacks a membrane anchor domain. Proc Natl Acad Sci U S A 1995;92:126-30.
18. Ulus T, Yildirir A, Demirtas S, et al. Serum gamma-glutamyl transferase activity: a new marker for stent restenosis? Atherosclerosis 2007;195:348-53.
19. Ruttmann E, Brant LJ, Concin H, et al. Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults. Circulation 2005;112:2130-7. (Pubitemid 41475806)
20. Meisinger C, Doring A, Schneider A, et al. Serum gamma- glutamyltransferase is a predictor of incident coronary events in apparently healthy men from the general population. Atherosclerosis 2006;189:297-302. (Pubitemid 44637220)
21. Stojakovic T, Scharnagl H, Trauner M, et al. Serum gammaglutamyl transferase and mortality in persons undergoing coronary angiography-The Ludwigshafen Risk and Cardiovascular Health Study. Atherosclerosis; 208:564-571
22. Dursunoglu N, Dursunoglu D. [Obstructive sleep apnea syndrome, endothelial dysfunction and coronary atherosclerosis]. Tuberk Toraks 2005;53:299-306.
23. Kanbay A, Kokturk O, Ciftci TU, et al. Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome. Respiration 2008;76:324-30.
24. Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-65. (Pubitemid 35315836)
25. Lee DH, Jacobs Jr DR. Association between serum gamma-glutamyltransferase and C-reactive protein. Atherosclerosis 2005;178:327-30. (Pubitemid 40193447)
26. Ulus T, Yildirir A, Sade LE, et al. Serum gamma-glutamyl transferase activity: new high-risk criteria in acute coronary syndrome patients? Coron Artery Dis 2008;19:489-95.
27. Paolicchi A, Emdin M, Passino C, et al. Beta-lipoprotein- and LDL-associated serum gamma-glutamyltransferase in patients with coronary atherosclerosis. Atherosclerosis 2006;186:80-5.
28. Paolicchi A, Emdin M, Ghliozeni E, et al. Images in cardiovascular medicine. Human atherosclerotic plaques contain gamma-glutamyl transpeptidase enzyme activity. Circulation 2004;109:1440.
29. Emdin M, Pompella A, Paolicchi A. Gamma-glutamyltransferase, atherosclerosis, and cardiovascular disease: triggering oxidative stress within the plaque. Circulation 2005;112:2078-80. (Pubitemid 41475797)
30. Targher G, Arcaro G. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007;191:235-40. (Pubitemid 46400718)
31. Lee DS, Evans JC, Robins SJ, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007;27:127-33. (Pubitemid 46360389)
32. Paolicchi A, Minotti G, Tonarelli P, et al. Gamma-glutamyl transpeptidase-dependent iron reduction and LDL oxidationea potential mechanism in atherosclerosis. J Investig Med 1999; 47:151-60. (Pubitemid 129541449)